Cell cycle control in breast cancer cells
C. Elizabeth Caldon(Garvan Institute of Medical Research), Elizabeth A. Musgrove(Garvan Institute of Medical Research)
Cited by 234
Related Papers
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer
|Journal of Experimental & Clinical Cancer Research|2025|1